LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Kodu・Aktsiate loetelu・Illumina Inc

Search

Illumina Inc

Suletud

Sektor Tervishoid

124.18 -4.18

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

123.96

Max

125.38

Põhinäitajad
By Trading Economics
Sissetulek	-1.9B -2B
Müük	30M 1.1B
Aktsiakasum	0.36
Kasumimarginaal	-179.099
Töötajad	10,590
EBITDA	-1.9B -1.9B

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+20.11 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	7. nov 2024

Turustatistika
By TradingEconomics
Turukapital	21B
Eelmine avamishind	128.36
Eelmine sulgemishind	124.18

Uudiste sentiment

By Acuity

34%

66%

107 / 365 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

N/A / 130.15 Toetus ja vastupanu

Illumina Inc Graafik

Seotud uudised

11. dets 2023, 18:43 UTC

Omandamised, ülevõtmised, äriostud

Illumina Submits SEC Form For Grail Divestiture

13. okt 2023, 18:42 UTC

Omandamised, ülevõtmised, äriostud

Illumina Gets European Commission Order to Divest Grail

5. märts 2024, 08:00 UTC

Tulu

Earnings Season Is Wrapping Up. Who Came Out Ahead, in 6 Charts. -- Barrons.com

18. dets 2023, 23:17 UTC

Omandamised, ülevõtmised, äriostud

Antitrust Regulators Issue New Merger Rules Amid Crackdown -- Barrons.com

18. dets 2023, 20:33 UTC

Omandamised, ülevõtmised, äriostud

Adobe-Figma Breakup Isn't Just a Win for Regulators. Why Consumers Should Be Cheering Too. -- Barrons.com

18. dets 2023, 09:48 UTC

Omandamised, ülevõtmised, äriostud

Illumina to Sell Grail. It's Giving Up on its Biotech Antitrust Battle. -- Barrons.com

18. dets 2023, 09:34 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Illumina, Roku, Uber, Broadcom, and More -- Barrons.com

9. nov 2023, 09:39 UTC

Tulu

These Stocks Are Moving the Most Today: Disney, Arm, Applovin, Affirm, Topgolf Callaway, and More -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Illumina Inc Prognoos

Hinnasiht

By TipRanks

20.11% tõus

12 kuu keskmine prognoos

Keskmine 149.4 USD 20.11%

Kõrge 242 USD

Madal 105 USD

Põhineb 20 Wall Streeti analüütiku instrumendi Illumina Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

20 ratings

12

Osta

7

Hoia

1

Müü

Põhineb 20 analüütiku instrumendi Illumina Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

N/A / 130.15Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

107 / 365 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Illumina Inc

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

902.74

UNH

UnitedHealth Group Inc

596.8

NVO

Novo Nordisk A-S

131.05

JNJ

Johnson and Johnson

164.37

ABBV

AbbVie Inc

193.18